Ultragenyx Pharmaceutical | Dochód Netto



Net Income Zmiana Data
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
Kyowa Hakko Kirin JPY 18.12B 5.02B 2024-09
MacroGenics USD 56.31M 111.97M 2024-09
Moderna USD -1120000000 1.13B 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Ultragenyx Pharmaceutical Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.